ECIO 2024

Discover our newest innovations and find out more about the latest clinical results at ECIO 2024

Sunday, 28/04
Monday, 29/04
Tuesday, 30/04

Sunday, 28th April

8:30 - 10:00 Sunday, 28th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

Speaker: G. Masi

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

Speaker: M. Lam

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

11:15 - 12:00 Monday, 29th April Auditorium 2

Scientific Paper Session

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

Speaker: G. Verset

13:15 - 14:00 Monday, 29th April Auditorium 2

Symposium

The new Pearls of TACE

Moderators: Prof. P. Pereira and Dr. G. Verset

Agenda

Evolving role of TACE in HCC - Prof. I. Bargellini
BioPearl™: The first resorbable drug eluting microspheres – T. Naccarato
Advantages of feeding artery reperfusion – Dr. T. Cascella
The BIOPEARL-ONE study - Prof. R. Iezzi
Panel discussion

15:00 - 16:30 Monday, 29th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 17:00 Monday, 29th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremSpheres™ Microspheres, QuiremScout™ Microspheres

8:30 - 10:30 Tuesday, 30th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Scientific Paper Session

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

Speaker: B. Rocco

17:00 - 18:30 Tuesday, 30th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

Monday, 29th April

8:30 - 10:00 Sunday, 28th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

Speaker: G. Masi

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

Speaker: M. Lam

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

11:15 - 12:00 Monday, 29th April Auditorium 2

Scientific Paper Session

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

Speaker: G. Verset

13:15 - 14:00 Monday, 29th April Auditorium 2

Symposium

The new Pearls of TACE

Moderators: Prof. P. Pereira and Dr. G. Verset

Agenda

Evolving role of TACE in HCC - Prof. I. Bargellini
BioPearl™: The first resorbable drug eluting microspheres – T. Naccarato
Advantages of feeding artery reperfusion – Dr. T. Cascella
The BIOPEARL-ONE study - Prof. R. Iezzi
Panel discussion

15:00 - 16:30 Monday, 29th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 17:00 Monday, 29th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremSpheres™ Microspheres, QuiremScout™ Microspheres

8:30 - 10:30 Tuesday, 30th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Scientific Paper Session

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

Speaker: B. Rocco

17:00 - 18:30 Tuesday, 30th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

Tuesday, 30th April

8:30 - 10:00 Sunday, 28th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

Speaker: G. Masi

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

15:00 - 16:30 Sunday, 28th April Auditorium 3

Clinical Focus Session

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

Speaker: M. Lam

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

11:15 - 12:00 Monday, 29th April Auditorium 2

Scientific Paper Session

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

Speaker: G. Verset

13:15 - 14:00 Monday, 29th April Auditorium 2

Symposium

The new Pearls of TACE

Moderators: Prof. P. Pereira and Dr. G. Verset

Agenda

Evolving role of TACE in HCC - Prof. I. Bargellini
BioPearl™: The first resorbable drug eluting microspheres – T. Naccarato
Advantages of feeding artery reperfusion – Dr. T. Cascella
The BIOPEARL-ONE study - Prof. R. Iezzi
Panel discussion

15:00 - 16:30 Monday, 29th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

15:00 - 17:00 Monday, 29th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremSpheres™ Microspheres, QuiremScout™ Microspheres

8:30 - 10:30 Tuesday, 30th April

Hands-on Device Training

Radioembolisation: dosimetry and administration systems

Speaker: Dr. Maarten Smits, Dr. Khalil Ramdhan

Featured products: QuiremScout™ Microspheres, QuiremSpheres™ Microspheres

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Scientific Paper Session

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

Speaker: B. Rocco

17:00 - 18:30 Tuesday, 30th April

Hands-on Device Training

Tumour ablation – heat-based ablation

Speakers: Dr. Marco Calandri, Dr. Guillaume Koch

Featured product: TATO Thermal Ablation Treatments for Oncology

Other activities

Ho-TARE Abstract

Transplantation after Holmium-166 radioembolization

Speaker: Dr Bibok

Ho-TARE Abstract

Tumour control and fast liver hypertrophy prior to liver surgery: a sequential approach with Ho-TARE and portal vein embolization

Speaker: M. Adami

BioPearl TACE Abstract

Histologic findings in the transplanted liver of a patient with HCC treated with chemoembolization using biodegradable drug-eluting particles loaded with doxorubicin

Speaker: T. Cascella

BioPearl TACE Abstract

Preliminary considerations of trans-arterial chemoembolization using doxorubicin-loaded resorbable drug-eluting microspheres in a small series of patients with unresectable hepatocellular carcinoma

Speaker: T. Cascella

Do you need more info about this product?

Our sales representatives are here for you.

Send us a message

First name *

Last name *

Function

Company *

Country *

E-mail address *

Question *

I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*

I wish to receive information and marketing updates from Terumo.

* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.

This webpage can include promotional content regarding one or several products... of Terumo Europe, or some procedures concerning the use or implantation of such products.This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public.

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.

ECIO 2024

Discover our newest innovations and find out more about the latest clinical results at ECIO 2024

Symposium

Clinical sessions

Booth activities

Would you like to set up a meeting or get more information?

Sunday, 28th April

8:30 - 10:00 Sunday, 28th April

Tumour ablation – heat-based ablation

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

11:15 - 12:00 Monday, 29th April Auditorium 2

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

13:15 - 14:00 Monday, 29th April Auditorium 2

The new Pearls of TACE

15:00 - 16:30 Monday, 29th April

Tumour ablation – heat-based ablation

15:00 - 17:00 Monday, 29th April

Radioembolisation: dosimetry and administration systems

8:30 - 10:30 Tuesday, 30th April

Radioembolisation: dosimetry and administration systems

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

17:00 - 18:30 Tuesday, 30th April

Tumour ablation – heat-based ablation

Monday, 29th April

8:30 - 10:00 Sunday, 28th April

Tumour ablation – heat-based ablation

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

11:15 - 12:00 Monday, 29th April Auditorium 2

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

13:15 - 14:00 Monday, 29th April Auditorium 2

The new Pearls of TACE

15:00 - 16:30 Monday, 29th April

Tumour ablation – heat-based ablation

15:00 - 17:00 Monday, 29th April

Radioembolisation: dosimetry and administration systems

8:30 - 10:30 Tuesday, 30th April

Radioembolisation: dosimetry and administration systems

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

17:00 - 18:30 Tuesday, 30th April

Tumour ablation – heat-based ablation

Tuesday, 30th April

8:30 - 10:00 Sunday, 28th April

Tumour ablation – heat-based ablation

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.5 / HAITI trial: TARE as consolidation therapy in unresectable colorectal liver mets

15:00 - 16:30 Sunday, 28th April Auditorium 3

Meet the PI: upcoming research - 143.6 / Radiation lobectomy using holmium-166 radioembolization: the RALLY study

11:15 - 12:00 Monday, 29th April Auditorium 2

Best at ECIO: incoming evidence for liver tumours - 222.1 / BIOPEARL-ONE: newly-designed BioPearl™ resorbable drug-eluting microspheres loaded with Doxorubicin for transarterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC): pros

13:15 - 14:00 Monday, 29th April Auditorium 2

The new Pearls of TACE

15:00 - 16:30 Monday, 29th April

Tumour ablation – heat-based ablation

15:00 - 17:00 Monday, 29th April

Radioembolisation: dosimetry and administration systems

8:30 - 10:30 Tuesday, 30th April

Radioembolisation: dosimetry and administration systems

10:30 - 12:00 Tuesday, 30th April Auditorium 3

Technical developments and clinical results in the treatment of liver tumours - 323.6 / Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response

17:00 - 18:30 Tuesday, 30th April

Tumour ablation – heat-based ablation

Other activities

Ho-TARE Abstract

Transplantation after Holmium-166 radioembolization

​Speak​er: ​Dr Bibok​​

Ho-TARE Abstract

Tumour control and fast liver hypertrophy prior to liver surgery: a sequential approach with Ho-TARE and portal vein embolization

​​Speaker: M. Adami

BioPearl TACE Abstract

Histologic findings in the transplanted liver of a patient with HCC treated with chemoembolization using biodegradable drug-eluting particles loaded with doxorubicin

​Speaker: T. Cascella​

BioPearl TACE Abstract

Speaker: Dr Bibok

Speaker: M. Adami

Speaker: T. Cascella

Speaker: T. Cascella